Founders Capital Management LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 48.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 953 shares of the healthcare conglomerate's stock after selling 882 shares during the quarter. Founders Capital Management LLC's holdings in UnitedHealth Group were worth $297,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of UNH. Financial Management Professionals Inc. boosted its holdings in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares during the last quarter. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares in the last quarter. Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares in the last quarter. Net Worth Advisory Group lifted its stake in UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after acquiring an additional 21 shares in the last quarter. Finally, Bensler LLC lifted its stake in UnitedHealth Group by 0.3% during the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate's stock valued at $3,637,000 after acquiring an additional 22 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Price Performance
Shares of NYSE:UNH traded up $4.80 during trading on Monday, hitting $341.49. 8,883,715 shares of the company's stock were exchanged, compared to its average volume of 13,684,542. The business's 50-day simple moving average is $296.49 and its 200 day simple moving average is $362.50. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a market cap of $309.27 billion, a price-to-earnings ratio of 14.80, a PEG ratio of 2.20 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.
Analyst Ratings Changes
A number of research firms have weighed in on UNH. Oppenheimer reduced their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research note on Friday, September 12th. Piper Sandler reduced their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Bank of America boosted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, KeyCorp lowered their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
Read Our Latest Stock Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.